AR031931A1 - Metodo de combinacion para el tratamiento de infecciones virales - Google Patents

Metodo de combinacion para el tratamiento de infecciones virales

Info

Publication number
AR031931A1
AR031931A1 ARP010105840A ARP010105840A AR031931A1 AR 031931 A1 AR031931 A1 AR 031931A1 AR P010105840 A ARP010105840 A AR P010105840A AR P010105840 A ARP010105840 A AR P010105840A AR 031931 A1 AR031931 A1 AR 031931A1
Authority
AR
Argentina
Prior art keywords
treatment
viral infections
combination method
polypeptide
pharmaceutically acceptable
Prior art date
Application number
ARP010105840A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR031931A1 publication Critical patent/AR031931A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ARP010105840A 2000-12-19 2001-12-17 Metodo de combinacion para el tratamiento de infecciones virales AR031931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25665700P 2000-12-19 2000-12-19

Publications (1)

Publication Number Publication Date
AR031931A1 true AR031931A1 (es) 2003-10-08

Family

ID=22973061

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105840A AR031931A1 (es) 2000-12-19 2001-12-17 Metodo de combinacion para el tratamiento de infecciones virales

Country Status (12)

Country Link
US (1) US20050065319A1 (enExample)
EP (1) EP1385534A2 (enExample)
JP (1) JP2005500981A (enExample)
CN (1) CN1481251A (enExample)
AR (1) AR031931A1 (enExample)
BR (1) BR0116253A (enExample)
CA (1) CA2431919A1 (enExample)
HU (1) HUP0302241A3 (enExample)
MX (1) MXPA03005526A (enExample)
NO (1) NO20032769L (enExample)
WO (1) WO2002056902A2 (enExample)
ZA (1) ZA200304560B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
BRPI0410360A (pt) * 2003-05-16 2006-08-01 Univ Maryland Biotech Inst composições para a sub-regulação da expressão de ccr5 e métodos para seu uso
CA2587903A1 (en) 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
JP2009517474A (ja) * 2005-11-30 2009-04-30 シェーリング コーポレイション Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
EP1976497A2 (en) * 2005-12-01 2008-10-08 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Treatment of viral infections
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
WO2013127299A1 (zh) * 2012-02-28 2013-09-06 中国人民解放军军事医学科学院毒物药物研究所 用于抑制hiv的多肽及其作用靶点
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
CA2224008C (en) * 1995-06-07 2009-08-18 Trimeris, Inc. The treatment of hiv and other viral infections using combinatorial therapy
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CA2365900A1 (en) * 1999-05-04 2000-11-09 Schering Corporation Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
PT1175402E (pt) * 1999-05-04 2005-11-30 Schering Corp Derivados da piperidina uteis como antagonistas ccr5
US6387930B1 (en) * 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists

Also Published As

Publication number Publication date
NO20032769L (no) 2003-08-18
HUP0302241A2 (hu) 2003-11-28
US20050065319A1 (en) 2005-03-24
WO2002056902A3 (en) 2002-12-05
WO2002056902A2 (en) 2002-07-25
CA2431919A1 (en) 2002-07-25
ZA200304560B (en) 2005-07-27
BR0116253A (pt) 2006-05-02
MXPA03005526A (es) 2003-10-06
EP1385534A2 (en) 2004-02-04
CN1481251A (zh) 2004-03-10
JP2005500981A (ja) 2005-01-13
HUP0302241A3 (en) 2005-06-28
NO20032769D0 (no) 2003-06-18

Similar Documents

Publication Publication Date Title
WO2002042295A3 (en) Peptides as met-ap2 inhibitors
ATE459357T1 (de) Kombinationen zur behandlung von multiplem myelom
MY141025A (en) Dose forms
BRPI0507628A (pt) composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto
PA8744101A1 (es) Metodo de terapia combinada para el tratamiento de la infeccion por el virus de la hepatitis c y composiciones farmaceuticas para usar en dicha terapia
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
CO5550426A2 (es) Novedoso metodo terapeutico
CO6382133A2 (es) Metodo para tratar o prevenir la trombosis usando etexilato de dabigatran o una sal del mismo con una eficacia mejorada sobre la terapia con warfarina convencional
AR031931A1 (es) Metodo de combinacion para el tratamiento de infecciones virales
PA8467401A1 (es) Procedimiento para tratar la insuficiencia cardiaca
ECSP22081150A (es) Composición farmacéutica para la prevención o tratamiento de enfermedad infecciosa viral de arn epidémica
AR119159A1 (es) Tratamientos de angioedema
DE60322075D1 (de) Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
ECSP014082A (es) Combinacion de secretagogos de hormona del crecimiento y antidepresivos
WO2003092608A3 (en) Methionine aminopeptidase-2 inhibitors and methods of use thereof
TW200501935A (en) Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
CO5200850A1 (es) Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion
AR037967A1 (es) Utilizacion de desoxipeganina en el tratamiento de la depresion clinica
HUP0300576A2 (hu) Érkárosító hatású, osztott dózisú gyógyászati készítmény
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
DE602004022578D1 (de) Antitumorale terpen-verbindungen
MD3121G2 (ro) Metodă de profilaxie a hepatitei virale B
UA38996A (uk) Спосіб лікування хронічного панкреатиту із супутньою ішемічною хворобою серця у людей похилого та старечого віку

Legal Events

Date Code Title Description
FB Suspension of granting procedure